Advertisement
Financing › Details
Rapid Genomics–LGC: investment, 202204 acquisition of Rapid Genomics by LGC
Period | 2022-04-01 | |
Money taker | Rapid Genomics LLC | |
Group | LGC (Group) | |
Money source | LGC Ltd. | |
Group | LGC (Group) | |
Product | Flex-Seq® Ex-L technology | |
Product 2 | AGRI LIFE SCIENCES | |
Person | Dearden, Mark (LGC 202204 Managing Director LGC Biosearch Technologies) | |
LGC Ltd.. (4/1/22). "Press Release: LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of NGS for High-throughput Genotyping Market in AgBio".
LGC has today announced the acquisition of Rapid Genomics, a provider of mid- to high-density Next-Generation Sequencing (NGS) kits and services for genotyping in the agrigenomics market.
Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing (NGS). Its Flex-Seq® Ex-L technology is provided to customers through kits and genotyping services, and allows high-throughput, cost-effective DNA analysis in plant, livestock and aquaculture genetics. This in turn enables development of more productive and resilient plants and animals, as well as food safety and animal health applications through the identification and screening of pathogens.
Mark Dearden, Managing Director, LGC, Biosearch Technologies, said, “We are excited to secure Rapid Genomics, which is an elegant fit with our core purpose of Science for a Safer World. This acquisition will enable future growth and development of our NGS high-throughput offerings in the agrigenomics space. Rapid Genomics is an excellent complement to our existing NGS and PCR genomics capabilities and we look forward to bringing the combined offering to our customers.”
Leandro Neves, CEO and President of Rapid Genomics, said, “We are honoured to join the LGC team. Our companies have worked together for several years with great synergy and shared vision. The access to LGC’s expertise in the field and broad technologies will have a multiplier effect on our ability to provide innovative solutions to our customers. We are excited to be part of LGC and leverage this opportunity to benefit our employees and customers.”
Founded in 2011 in Gainesville, Florida, USA, Rapid Genomics currently has 30 employees.
Record changed: 2022-04-02 |
Advertisement
More documents for LGC (Group)
- [1] Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY....
- [2] LGC Ltd.. (4/1/22). "Press Release: LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of NGS for High-throughput Genotyping Market in AgBio"....
- [3] LGC. (3/3/21). "Press Release: LGC Acquires Paragon Scientific, Strengthening Its Position in Reference Materials". London....
- [4] LGC. (11/25/20). "Press Release: LGC Offers Regulated Bioanalysis on the Sciex TripleTOF 6600 High-Resolution Mass Spectrometry Platform". London....
- [5] LGC Ltd.. (11/26/18). "Press Release: LGC Acquires Seracare Life Sciences, Strengthening Its Position in Clinical Quality Control Tools"....
- [6] LGC Ltd.. (4/3/17). "Press Release: LGC Acquires Axolabs and Invests in GMP Manufacturing Capacity for Therapeutic Nucleic Acids"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top